The purpose of this study is to examine how brain function and behavior interact in the human brain using electroencephalography (EEG), a brain imaging tool that does not require surgery. We are recruiting two groups of individuals: 1.) those that experienced a stroke and 2.) those that have not experienced a stroke.

EGID Partners is an online cohort of patients with eosinophilic gastrointestinal diseases (EGIDs), like eosinophilic esophagitis (EoE), eosinophilic gastritic (EG), eosinophilic gastroenteritis (EGE), and/or eosinophilic colitis (EC). It is a way to conduct important clinical research through surveys, and by filling out the initial survey, as well as follow-up surveys every 6 months, you can help answer important questions about living with EGIDs. We are also looking for people without EGIDs to provide information as well, so we can make comparisons between those do and don't have EGIDs. Adults as well as parents/caregivers of children are eligible. Find out more at www.egidpartners.org

We will collect one more round of data from participants >= 45 years and analyze factors associated with aging and cognitive function.

The purpose of this research study is to determine the cause and mechanism of alpha-gal mammalian meat allergy. Alpha-gal is a novel food allergy that we have only come to recognize in recent years. It seems to preferentially affect people who reside in certain geographic areas, with the southeastern US (including North Carolina) being one.

The purpose of this research study is to determine the effectiveness of the "Teens Taking Charge IOP" on adolescents who have experienced trauma (and their caregivers).

To generate information on the undergraduate experience at the University of North Carolina at Chapel Hill from currently enrolled students. This survey is processed every other year.

The ASPIRE trial aims to study anticoagulant medications in patients who have had an intracerebral hemorrhage (bleeding in the brain) who also have atrial fibrillation (irregular heartbeats). Participants who agree to study participation will receive either Aspirin or Apixaban and followed for 12-36 months to see if they have any other strokes, and follow their general recovery after stroke.

We are exploring the relationship between participation in the FIT Program with health outcomes, recidivism, and healthcare utilization for people who are coming out of incarceration and who have chronic illnesses.

The primary purpose of this work is to engage a broad group of stakeholders to implement a patient-centered approach to the de-adoption of self-monitored blood glucose among non-insulin-treated patients with Type two Diabetes Mellitus. We will evaluate the effectiveness of Rethink the Strip finalize and package it for nationwide dissemination.

This registry will collect data on the strategies used to achieve a diagnosis of Idiopathic Pulmonary Fibrosis (IPF) and Chronic Fibrosing Interstitial Lung Disease with Progressive Phenotype (ILD) and the treatment and management efforts applied throughout study follow-up, clinical outcome events and patient reported outcome data. Blood samples will be collected periodically throughout the study for use in future research efforts. For participants with non-IPF, chronic fibrosing ILD with progressive phenotype, HRCT images will be collected throughout the study for use in future research efforts.